Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials-Reference-Cited by-同舟云学术

Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials

Published:2016-04 Issue:4 Volume:17 Page:519-531
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Temel Jennifer S,Abernethy Amy P,Currow David C,Friend John,Duus Elizabeth M,Yan Ying,Fearon Kenneth C

Funder

Mundipharma AB

Publisher

Elsevier BV

Subject

Oncology

Reference33 articles.

1. Understanding the mechanisms and treatment options in cancer cachexia;Fearon;Nat Rev Clin Oncol,2013

2. Definition and classification of cancer cachexia: an international consensus;Fearon;Lancet Oncol,2011

3. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis;Fearon;Am J Clin Nutr,2006

4. Correlation between the international consensus definition of the Cancer Anorexia-Cachexia Syndrome (CACS) and patient-centered outcomes in advanced non-small cell lung cancer;LeBlanc;J Pain Symptom Manage,2015

5. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment;Prado;Clin Cancer Res,2009

Cited by 482 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Muscle wasting and frailty in head and neck cancer;Head and Neck Cancer Rehabilitation;2025

2. In vitro pharmacological characterization of growth hormone secretagogue receptor ligands using the dynamic mass redistribution and calcium mobilization assays;European Journal of Pharmacology;2024-10

3. Ponsegromab for the Treatment of Cancer Cachexia;New England Journal of Medicine;2024-09-14

4. Efficacy and safety of pharmacotherapy for cancer cachexia: A systematic review and network meta‐analysis;Cancer Medicine;2024-09

5. Ernährungsmedizin in der Onkologie - ein Update;Im Fokus Onkologie;2024-09